Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$621,615,444
+$139,323,928 QoQ
Shares Held
518,259
-1.2% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
3.57%
of 13F equity value
Holder Rank
#123
of 4,621 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Employees Provident Fund Board holds $1,255,262,333 across 8 Drug Manufacturers - General names. LLY ranks #1 (49.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
518,259 | $621,615,444 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,640,333 | $209,755,987 | |
| 3 | BIIB |
Biogen Inc.
|
704,196 | $152,148,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
535,502 | $68,812,007 | |
| 5 | JNJ |
Johnson & Johnson
|
266,023 | $67,561,861 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
488,657 | $61,736,925 | |
| 7 | ABBV |
AbbVie Inc.
|
163,093 | $41,040,722 | |
| 8 | AMGN |
Amgen Inc
|
90,000 | $32,590,800 |
All Filings in LLY
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $621,615,444 | 518,259 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $482,291,516 | 524,361 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $340,773,536 | 317,093 | Shares | Sole | 2026-03-03 | |
| 2025-09-30 | $474,460,105 | 621,835 | Shares | Sole | 2026-03-17 | |
| 2025-06-30 | $430,982,648 | 552,875 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $322,089,207 | 389,981 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $210,466,500 | 272,625 | Shares | Sole | 2026-03-17 | |
| 2024-09-30 | $126,624,746 | 142,927 | Shares | Sole | 2026-03-17 | |
| 2024-06-30 | $140,648,972 | 155,348 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $28,628,928 | 36,800 | Shares | Sole | 2026-03-18 | |
| 2023-12-31 | $22,115,984 | 37,940 | Shares | Sole | 2026-03-18 | |
| 2023-09-30 | $72,820,862 | 135,574 | Shares | Sole | 2026-03-18 | |
| 2023-06-30 | $20,483,639 | 43,677 | Shares | Sole | 2026-03-31 | |
| 2023-03-31 | $6,331,634 | 18,437 | Shares | Sole | 2026-03-18 | |
| No filing history on record for this holder in this stock. | ||||||